Overexpression of gastrin-releasing peptide receptors in tumor-associated blood vessels of human ovarian neoplasms

Cellular Oncology

Volumn 29, Issue 5, 2007, Pages 421-433

  Fleischmann, Achim ^a   Waser, Beatrice ^a   Reubi, Jean Claude ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Autoradiography; Bombesin receptors; GRP receptors; Neoplasm; Ovary; Tumoral vasculature

Indexed keywords

BOMBESIN; GASTRIN RELEASING PEPTIDE RECEPTOR; IODINE 125; RADIOLIGAND;

ANDROBLASTOMA; ANGIOGENESIS; ARTICLE; AUTORADIOGRAPHY; BLOOD VESSEL; CANCER INCIDENCE; CANCER LOCALIZATION; CELL DENSITY; CONTROLLED STUDY; DRUG TARGETING; FEMALE; GRANULOSA CELL TUMOR; HUMAN; HUMAN TISSUE; IN VITRO STUDY; METASTASIS; OVARY CARCINOMA; OVARY METASTASIS; OVARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; TISSUE SECTION; TUMOR BLOOD FLOW; TUMOR CELL; TUMOR VASCULARIZATION;

AUTORADIOGRAPHY; BINDING, COMPETITIVE; FEMALE; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN NEOPLASMS; RECEPTORS, BOMBESIN;

EID: 34547888717     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. A. Jemal, T. Murray, E.Ward et al., Cancer statistics, 2005, CA Cancer J. Clin. 55 (2005), 10-30.
2. F.A. Tavassoli and P. Devilee, Pathology and genetics of tumours of the breast and female genital organs, in: World Health Organisation Classification of Tumours, IARC Press, Lyon, 2003.
3. J.C. Reubi, Peptide receptors as molecular targets for cancer diagnosis and therapy, Endocr. Rev. 24 (2003), 389-427.
4. A.V. Schally, K. Szepeshazi, A. Nagy, A.M. Comaru-Schally and G. Halmos, New approaches to therapy of cancers of the stomach, colon and pancreas based on peptide analogs, Cell Mol. Life Sci. 61 (2004), 1042-1068.
5. N. Bunnett, Gastrin-releasing peptide, in: Gut Peptides: Biochemistry and Physiology, J.H. Walsh, G.J. Dockray, eds, Raven Press, Ltd, New York, 1994, pp. 423-445.
6. S.R. Nagalla, B.J. Barry, K.C. Creswick et al., Cloning of a receptor for amphibian [Phe13]bombesin distinct from the receptor for gastrin-releasing peptide: Identification of a fourth bombesin receptor subtype (BB4), Proc. Natl. Acad. Sci. USA 92 (1995), 6205-6209.
7. G.S. Kroog, R.T. Jensen and J.F. Battey, Mammalian bombesin receptors, Med. Res. Rev. 15 (1995), 389-417.
8. F. Cuttitta, D.N. Carney, J.Mulshine, et al., Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer, Nature 316 (1985), 823-826.
9. M. Bologna, C. Festuccia, P. Muzi, L. Biordi and M. Ciomei, Bombesin stimulates growth of human prostatic cancer cells in vitro, Cancer 63 (1989), 1714-1720.
10. A. Pansky, A. De Weerth, E. Fasler-Kan et al., Gastrin releasing peptide-preferring bombesin receptors mediate growth of human renal cell carcinoma, J. Am. Soc. Nephrol. 11 (2000), 1409-1418.
11. M. Gugger and J.C. Reubi, Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast, Am. J. Pathol. 155 (1999), 2067-2076.
12. R. Markwalder and J.C. Reubi, Gastrin-releasing peptide receptors in the human prostate: Relation to neoplastic transformation, Cancer Res. 59 (1999), 1152-1159.
13. S. Kim, W. Hu, D.R. Kelly et al., Gastrin-releasing peptide is a growth factor for human neuroblastomas, Ann. Surg. 235 (2002) 621-629; discussion 629-630.
14. J.C. Reubi, S. Wenger, J. Schmuckli-Maurer, J.C. Schaer and M. Gugger, Bombesin receptor subtypes in human cancers: Detection with the universal radioligand (125)I-[D-TYR(6), beta-ALA(11), PHE(13), NLE(14)] bombesin(6-14), Clin. Cancer Res. 8 (2002), 1139-1146.
15. M. Heuser, T. Schlott, A.V. Schally et al., Expression of gastrin releasing peptide receptor in renal cell carcinomas: A potential function for the regulation of neoangiogenesis and microvascular perfusion, J. Urol. 173 (2005), 2154-2159.
16. A. Fleischmann, B. Waser, J.O. Gebbers and J.C. Reubi, Gastrin-releasing peptide receptors in normal and neoplastic human uterus: Involvement of multiple tissue compartments, J. Clin. Endocrinol. Metab. 90 (2005), 4722-4729.
17. I. Chatzistamou, A.V. Schally, B. Sun, P. Armatis and K. Szepeshazi, Inhibition of growth of OV-1063 human epithelial ovarian cancers and c- jun and c- fos oncogene expression by bombesin antagonists, Br. J. Cancer 83 (2000), 906-913.
18. I. Chatzistamou, A.V. Schally, K. Szepeshazi et al., Inhibition of growth of ES-2 human ovarian cancers by bombesin antagonist RC-3095, and luteinizing hormone-releasing hormone antagonist Cetrorelix, Cancer Lett. 171 (2001), 37-45.
19. J.B. Engel, G. Keller, A.V. Schally et al., Effective inhibition of experimental human ovarian cancers with a targeted cytotoxic bombesin analogue AN-215, Clin. Cancer Res. 11 (2005), 2408-2415.
20. B. Sun, A.V. Schally and G. Halmos, The presence of receptors for bombesin/GRP and mRNA for three receptor subtypes in human ovarian epithelial cancers, Regul. Pept. 90 (2000), 77-84.
21. C. Van de Wiele, F. Dumont, R. Vanden Broecke et al., Technetium-99m RP527, a GRP analogue for visualisation of GRP receptor-expressing malignancies: A feasibility study, Eur. J. Nucl. Med. 27 (2000), 1694-1699.
22. B. Nock, A. Nikolopoulou, E. Chiotellis et al., [99mTc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging, Eur. J. Nucl. Med. Mol. Imaging 30 (2003), 247-258.
23. E.S. Bamberger and C.W. Perrett, Angiogenesis in epithelian ovarian cancer, Mol. Pathol. 55 (2002), 348-359.
24. A. Martinez, A new family of angiogenic factors, Cancer Lett. 28 (2005), 28.
25. A. Fleischmann, U. Laderach, H. Friess, M.W. Buechler and J.C. Reubi, Bombesin receptors in distinct tissue compartments of human pancreatic diseases, Lab. Invest. 80 (2000), 1807-1817.
26. S.R. Vigna, C.R. Mantyh, A.S. Giraud et al., Localization of specific binding sites for bombesin in the canine gastrointestinal tract, Gastroenterology 93 (1987), 1287-1295.
27. T.K. Pradhan, T. Katsuno, J.E. Taylor et al., Identification of a unique ligand which has high affinity for all four bombesin receptor subtypes, Eur. J. Pharmacol. 343 (1998), 275-287.
28. J.C. Reubi and B. Waser, Concomitant expression of several peptide receptors in neuroendocrine tumours: Molecular basis for in vivo multireceptor tumour targeting, Eur. J. Nucl. Med. Mol. Imaging 30 (2003), 781-793.
29. C. Bjenning, A.P. Farrell and S. Holmgren, Bombesin-like immunoreactivity in skates and the in vitro effect of bombesin on coronary vessels from the longnose skate, Raja rhina, Regul. Pept. 35 (1991), 207-219.
30. S. Clive, D. Jodrell and D. Webb, Gastrin-releasing peptide is a potent vasodilator in humans, Clin. Pharmacol. Ther. 69 (2001), 252-259.
31. T.N. Luu, A.H. Chester, G.S. O'Neil et al., Different responses of the human gastroepiploic and internal mammary arteries to vasoactive peptides, Am. J. Physiol. 264 (1993), H583-H587.
32. K.A. Yule and S.R. White, Migration of 3T3 and lung fibroblasts in response to calcitonin gene-related peptide and bombesin, Exp. Lung. Res. 25 (1999), 261-273.
33. J.S. Kim, V.S. McKinnis and S.R. White, Migration of Guinea pig airway epithelial cells in response to bombesin analogues, Am. J. Respir. Cell. Mol. Biol. 16 (1997), 259-266.
34. J.A. Jensen, R.E. Carroll and R.V. Benya, The case for gastrin-releasing peptide acting as a morphogen when it and its receptor are aberrantly expressed in cancer, Peptides 22 (2001), 689-699.
35. L. Levine, J.A. Lucci 3rd, B. Pazdrak et al., Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells, Cancer Res. 63 (2003), 3495-3502.
36. L. Levine, J.A. Licci 3rd, C.M. Townsend Jr, and M.R. Hellmich, Expression of gastrin-releasing peptide receptors in endometrial cancer, J. Am. Coll. Surg. 196 (2003), 898-904.
37. A. Martinez, E. Zudaire, M. Julian, T.W. Moody and F. Cuttitta, Gastrin-releasing peptide (GRP) induces angiogenesis and the specific GRP blocker 77427 inhibits tumor growth in vitro and in vivo, Oncogene 24 (2005), 4106-4113.
38. A.M. Bajo, A.V. Schally, K. Groot and K. Szepeshazi, Bombesin antagonists inhibit proangiogenic factors in human experimental breast cancers, Br. J. Cancer 90 (2004), 245-252.
39. M. Narazaki and G. Tosato, Targeting coagulation to the tumor microvasculature: Perspectives and therapeutic implications from preclinical studies. J. Natl. Cancer Inst. 97 (2005), 705-707.
40. G. Schwartsmann, L.P. DiLeone, M. Horowitz, D. Schunemann, A. Cancella, A.S. Pereira, M. Richter, F. Souza, A.B. da Rocha, F.H. Souza, P. Pohlmann and G. De Nucci, A phase I trial of the bombesin/gastrin-releasing peptide (BN/GRP) antagonist RC3095 in patients with advanced solid malignancies, Invest. New Drugs 24 (2006), 403-412.